3.24
影响溶解的因素：多晶型、无定形和假多晶型
多晶型是指药物以多种结晶形式存在，称为多晶型。近年来，该术语的涵盖范围已扩展为包括溶剂化物（含有溶剂的形式）、无定形形式（非结晶形式）和脱溶剂化物（已去除溶剂的形式）。
一些多晶型晶体的水溶性低于无定形晶体，导致吸收不完全。例如，氯霉素口服混悬液存在多种晶型，表明体内药物浓度取决于更易溶解和更易吸收…
药物的溶出度受多晶型现象的影响，多晶型是指药物物质以多种晶体形式存在，如多晶型物、溶剂化物和非晶型形式。
一种药物的不同晶型具有相同的化学式，但具有不同的化学结构，因此表现出不同的物理性质。
例如，氯霉素混悬液具有多种晶型。然而，高比例的高溶解性β多晶型可增强药物吸收。
亚稳态多晶型物在生产过程中可能转化为更稳定的形式，从而导致片剂开裂或阻碍颗粒压片等问题。
在药物生产过程中，某些药物会与溶剂相互作用形成溶剂化物。这些溶剂化物的不同晶型被称为假多晶型。
当溶剂为水时，会形成水合物。对于红霉素水合物，溶解百分比随时间变化的曲线显示出二水合物、一水合物和无水物形式具有不同的溶解度模式。
最后，无定形物缺乏晶体结构，在水溶液中的溶解速度比晶体更快。
View the full transcript and gain access to JoVE Core videos
Q1: What is polymorphism and how does it affect drug dissolution?
Polymorphism refers to a drug substance existing in multiple crystalline forms with the same chemical formula but different structures and physical properties. Different polymorphs exhibit varying solubility rates; for example, chloramphenicol's highly soluble β-polymorph enhances drug absorption compared to less soluble forms. This variation directly impacts dissolution rates and bioavailability.
Q2: Why do metastable polymorphs cause problems during drug manufacturing?
Metastable polymorphs can convert to more stable forms during manufacturing, causing tablet cracking or preventing granulation compression. These transitions occur because metastable forms possess higher free energy than stable polymorphs. Such changes may require product reformulation to maintain pharmaceutical quality and efficacy.
Q3: What are solvates and pseudopolymorphs in pharmaceutical formulations?
Solvates form when drugs interact with solvents during manufacturing. When water is the solvent, specific crystalline forms called hydrates are produced. These pseudopolymorphs possess different solubility characteristics than their anhydrous counterparts; for instance, erythromycin hydrates show distinct dissolution patterns compared to the anhydrate form.
Q4: How do amorphous drug forms compare to crystalline forms in dissolution?
Amorphous forms lack crystalline structures and dissolve more rapidly in aqueous solutions than crystalline forms. Being less structurally rigid, amorphous drugs often exhibit faster dissolution rates. However, some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, potentially leading to incomplete absorption.
Q5: Why does anhydrous ampicillin absorb faster than ampicillin trihydrate?
The anhydrous form of ampicillin dissolves more quickly than ampicillin trihydrate, resulting in faster absorption. This difference stems from the distinct solubility characteristics of hydrated versus anhydrous forms. Faster dissolution of the anhydrous form enables more rapid drug availability for mechanisms of drug absorption paracellular transcellular and vesicular transport.
Q6: What determines whether a polymorph is stable or metastable?
The most stable polymorph has the lowest free energy, making it thermodynamically favored. Metastable polymorphs possess higher free energy and may spontaneously transition to more stable forms over time. This energy difference explains why certain crystal forms persist during manufacturing while others convert, potentially causing formulation problems.
Q7: How do hydrate forms of erythromycin differ in their dissolution behavior?
Erythromycin exists in dihydrate, monohydrate, and anhydrate forms, each displaying different solubility patterns. When percent dissolved is plotted against time, these hydrate forms show distinct dissolution curves. The variation in water content directly influences the crystal structure and aqueous solubility of each form.